Literature DB >> 9018286

Sickle cell disease expenditures and outcomes.

A N Schechter1.   

Abstract

Mesh：

Year:  1997        PMID： 9018286      PMCID： PMC1381836     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  6 in total

1.  Sickle cell anemia--basic research reaches the clinic.

Authors:  A N Schechter; G P Rodgers
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

2.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control.

Authors:  L Jia; C Bonaventura; J Bonaventura; J S Stamler
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

3.  What determines severity in sickle-cell disease?

Authors:  A N Schechter; H F Bunn
Journal:  N Engl J Med       Date:  1982-02-04       Impact factor: 91.245

4.  Bone marrow transplantation for sickle cell disease.

Authors:  M C Walters; M Patience; W Leisenring; J R Eckman; J P Scott; W C Mentzer; S C Davies; K Ohene-Frempong; F Bernaudin; D C Matthews; R Storb; K M Sullivan
Journal:  N Engl J Med       Date:  1996-08-08       Impact factor: 91.245

5.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

6.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; M L Terrin; R D Moore; G J Dover; F B Barton; S V Eckert; R P McMahon; D R Bonds
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.